Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

1 comment By Julie Grisham, MS, Science Writer/Editor   |   Monday, July 16, 2012 Memorial Sloan-Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells. read more

Original post:
Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • email
  • LinkedIn
  • RSS
  • Tumblr
Share